News | April 11, 2024
Syntegon showcases oral solid dosage portfolio at Achema
Fluid bed processes: drying, granulating, and coating in just one product container
Fluid bed processes: drying, granulating, and coating in just one product container
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
These observations are procedural in nature and will be responded within the stipulated time
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
The observations are procedural in nature and will be responded to within the stipulated time
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
A game changing solution for the pharmaceutical industry
Enhertu now has five approved indications with the latest in HER2-expressing (IHC 3+) metastatic cancers
First and only immunotherapy to demonstrate survival benefit in this setting in a global Phase III trial
Subscribe To Our Newsletter & Stay Updated
